Stratagene Acquires Hycor; New Firm Will Focus on Molecular Dx | GenomeWeb

NEW YORK, July 24 - Stratagene will acquire Hycor, creating a molecular diagnostics company that will combine Hycor's instrumentation systems and reagents technologies with Stratagene's gene-discovery and target-identification muscle, the firms said today.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.